addarrow-downarrow-outlinearrow-outline-leftarrow-upclosedownloadhelpinfolinklink-external-outlinemenusearchshare-emailshare-facebookshare-linkedinshare-twitter
Published:
Last Updated:
9 Jul 2020

Improving Access and Affordability for Biopharmaceuticals in Emerging Markets

A briefing paper from the Biopharmaceutical Think Tank discussion at the 2019 IFC Global Private Health Care Conference Author: Chrissy Bishop, Tim Gamble

IFC’s Global Private Healthcare Conference took place in March 2019, with a primary aim to spark discussion and drive action around the private health sector and its role in meeting critical challenges in emerging markets. The theme of the 2019 conference was Disrupting the Present, Building the Future—Embracing Innovation to Deliver Results. Alongside the main conference sessions, invited health care thought leaders, policy experts, investors, and industry representatives from around the globe gathered for a think tank session to discuss some of the most pressing challenges, trends and opportunities related to biopharmaceuticals in emerging markets. This briefing paper reflects key themes and important points from the discussion that took place, and leverages additional insights, research, and analysis to bring light to this important topic.

Info